|
Volumn 30, Issue 8, 1998, Pages 3943-3944
|
Development of severe adverse effects after discontinuing amiodarone therapy in human heart transplant recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
CYCLOSPORIN A;
DEETHYLAMIODARONE;
DRUG METABOLITE;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DRUG BLOOD LEVEL;
DRUG ELIMINATION;
DRUG WITHDRAWAL;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIPIDOSIS;
LUNG TOXICITY;
NEPHROTOXICITY;
PRIORITY JOURNAL;
AMIODARONE;
ANTI-ARRHYTHMIA AGENTS;
BILIRUBIN;
CYCLOSPORINE;
DRUG INTERACTIONS;
HALF-LIFE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
NEUTROPHILS;
|
EID: 0032437489
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01296-2 Document Type: Conference Paper |
Times cited : (9)
|
References (9)
|